Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2103 (LINC02103)
- Target
- LINC02103
- Molecular classification
- Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA)
01
Overview
Long intergenic non-protein coding RNA 2103 (LINC02103) is a human long intergenic non-coding RNA (lincRNA), defined as an autonomously transcribed RNA longer than 200 nucleotides that does not overlap annotated protein-coding genes. LincRNAs, including LINC02103, are classified within the long non-coding RNA family and distinguished by their intergenic genomic localization. LincRNAs in general participate in diverse regulatory functions such as chromatin remodeling, transcriptional regulation, stabilization of RNAs, and modulation of gene expression, sometimes in a tissue-specific manner. While some lincRNAs have known roles in disease (such as Xist in X chromosome inactivation or HOTAIR in cancer), LINC02103 itself does not currently have an ascribed biological or disease-associated function in public domain sources. There are no reported drugs, clinical biomarkers, or safety concerns associated with this RNA. If new studies emerge with more functional or disease-specific data regarding LINC02103, these classifications may be updated.
- Other names
- LINC02103
02
Mechanism of action
Not applicable (no drugs identified that directly target this lincRNA)
03
Biological functions
Gene expression regulationChromatin and genome architecture modulationRNA stabilizationTranscription regulationEnhancer-associated activityOther (due to limited direct function assignment to LINC02103 specifically)
04
Disease associations
Other (no direct evidence that LINC02103 is clinically linked to disease such as cancer, inflammation, etc.; lincRNAs in general may play diverse regulatory roles in disease contexts)
05
Safety considerations
None reported (lincRNAs are non-coding RNAs and, as of current knowledge, do not pose direct safety concerns; no clinical therapeutic interventions developed for LINC02103)
06
Interacting drugs
None reported (no information available on drugs targeting LINC02103)
07
Biomarkers
None established (no biomarker status for LINC02103 reported in available indexed sources)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2103 (LINC02103).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2103 (LINC02103).